We recently published a list of 10 Stocks Lead Friday’s Charge. In this article, we are going to take a look at where Tempus ...
Tempus AI, Inc. (NASDAQ:TEM – Get Free Report)’s share price traded down 0% during mid-day trading on Thursday after an insider sold shares in the company. The stock traded as low as $47.12 and last ...
CHICAGO (AP) — CHICAGO (AP) — Tempus AI Inc. (TEM) on Monday reported a loss of $13 million in its fourth quarter. The Chicago-based company said it had a loss of 8 cents per share.
Amid the market volatility and intense macroeconomic uncertainty, is it wise for Hinge Health to test the public markets?
Seven board members and company insiders dumped a total of $4.3 million worth of Nancy Pelosi's latest stock holding, Tempus ...
Tempus AI stock surged 40% YTD, driven by acquisitions and investor confidence in healthcare AI. Can its momentum spark ...
Cathie Wood’s ARK ETFs made some significant trades on Tuesday, including selling of Meta Platforms’ (META) stock, while boosting its ...
Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve ratings firms ...
Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. TEM, Advanced Micro Devices Inc. AMD, and Meta ...
Detailed price information for Uipath Inc Cl A (PATH-N) from The Globe and Mail including charting and trades.
In the biotech sphere, ARK ETFs continued to accumulate shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Intellia Therapeutics Inc (NASDAQ: NTLA ), with purchases of 67,787 and 194,844 shares, ...
Kimia Therapeutics, Inc. (Kimia), a biotechnology company generating a chemical atlas for treating human disease, today announced the appointment of Imran S. Haque, Ph.D., to the role of chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results